Biology Atlas

Map / Assays

assay · intermediate · partly written

Microsomal stability assay

Liver microsomes, membrane fragments rich in CYP enzymes, are incubated with a compound and the disappearance of the parent is used to estimate intrinsic clearance.

Also called: liver microsome stability, HLM stability

How well does it predict human clearance? more

In a compiled database, human microsome predictions through the well-stirred model had an average fold error of 2.0 and 42.2 percent were within 2-fold (83 drugs); by extraction class the fold error was 1.3, 2.7 and 2.9 for low, intermediate and high. Obach tested 29 drugs and found predictions best when both blood binding and binding to the microsomes were included; basic compounds bound microsomes most (unbound fraction 0.11 to 1.0) and for acidic compounds ignoring binding gave poor predictions. In a blinded multi-company set of 19 drugs, microsome-based prediction with binding corrections was within 2-fold for 75 percent. 123

Reported, not yet replicated

What the vendor page says more

The vendor describes the incubation and readout and names no limitation. A no-NADPH control to separate enzyme loss from chemical instability is standard practice but the vendor page cited for it was not opened. 4

Reported, not yet replicated

Question answered

How fast liver cytochrome P450 enzymes remove the compound, as intrinsic clearance, so human clearance can be estimated by scaling. 41

Reported, not yet replicated

Readout physical

Remaining parent compound at set times, measured by mass spectrometry; the slope of ln(remaining) against time gives a rate constant k, then half-life and intrinsic clearance in microlitres per minute per mg protein. 4

Reported, not yet replicated

Not measured

Uptake into cells, bile, and anything not in the membrane fragment; the vendor page lists hepatocytes and S9 as alternatives. Binding to the microsomes themselves also distorts the result. 42

Reported, not yet replicated

Setting

Where in cascade

Sample prep

Compound incubated with microsomes and the cofactor NADPH at 37 C; aliquots stopped in cold acetonitrile at set times. 4

Reported, not yet replicated

Still open here

Not yet written: Conditions, Throughput, Time per run, Cost, Engineerable variants, Use cases, Before after, Capital, Emerging, ML role, Data availability.

Linked from

Sources

  1. Bowman CM, Benet LZ. In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction. J Pharm Sci (2019). paper; opened 2026-11-17 all records citing this
  2. Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos (1999). paper; opened 2026-11-17 all records citing this
  3. Ring BJ, Chien JY, Adkison KK, Jones HM, et al.. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance. J Pharm Sci (2011). paper; opened 2026-11-17 all records citing this
  4. Microsomal clearance and stability assay (Domainex). Domainex. vendor-page, not peer reviewed; opened 2026-11-17 all records citing this
Where it sits on the map
History of this record (1)

This record has been changed 1 time, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.

Throughput class
medium
Status
partly written
Last updated
2026-11-17
Record
content/assays/microsomal-stability-assay.json